Sung Jong Jin, Ahn Ae Ri, Park Ho Sung, Jang Kyu Yun, Moon Woo Sung, Lee Ju-Hyung, Kim Kyoung Min, Chung Myoung Ja
Department of Pathology, Jeonbuk National University Medical School, Jeonju, Jeollabuk 54907, Republic of Korea.
Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, Jeollabuk 54907, Republic of Korea.
Oncol Lett. 2024 Sep 5;28(5):535. doi: 10.3892/ol.2024.14668. eCollection 2024 Nov.
The long survival of patients with primary cancer increases the chance of such patients developing second primary cancer (SPC). The development of SPC in cancer survivors exerts a large psychological, social and economic burden on patients and their families. The aim of the present study was to assess the risk of cancer survivors developing SPC. The study included patients who had been diagnosed with a first primary cancer in five organs (stomach, colorectum, lung, breast and thyroid), which are the five most common sites of cancer in patients from Korea, at the regional cancer center in Jeonbuk National University Hospital between January 2007 and December 2009. The standardized incidence ratio (SIR) of SPC according to sex and site was calculated from 5,209 patients who were followed up to September 2017. General incidence was acquired from the National Cancer Registry of Republic of Korea. SPC occurred in 6.2% (323/5,209) of patients, and the incidence of SPC among the five major types of cancer was in the order of breast (8.8%, 46/524), colorectum (8.6%, 86/1,003), gastric (6.6%, 89/1,358), thyroid (4.7%, 67/1,437) and lung cancer (3.9%, 35/887). When all SPC sites were included, the SIRs of SPC in patients with colorectal cancer and breast cancer were >1.0 (1.21 and 1.66, respectively). Breast cancer and thyroid cancer exhibited a high site relationship (P<0.05), and colorectal cancer had a high site relationship with gastric cancer (P<0.05). The present study analyzed the incidence and pattern of SPC in patients with cancer who were diagnosed with primary carcinoma in five organs. The results of the study may be useful for effective follow-up and early detection of SPC in patients with cancer.
原发性癌症患者的长期生存增加了这些患者发生第二原发性癌症(SPC)的几率。癌症幸存者发生SPC会给患者及其家庭带来巨大的心理、社会和经济负担。本研究的目的是评估癌症幸存者发生SPC的风险。该研究纳入了2007年1月至2009年12月期间在全北国立大学医院区域癌症中心被诊断患有五种器官(胃、结肠直肠、肺、乳腺和甲状腺)中第一种原发性癌症的患者,这五个器官是韩国患者中最常见的癌症发生部位。根据性别和部位计算了5209例随访至2017年9月的患者的SPC标准化发病比(SIR)。一般发病率来自大韩民国国家癌症登记处。SPC发生在6.2%(323/5209)的患者中,五种主要癌症类型中SPC的发病率依次为乳腺癌(8.8%,46/524)、结肠直肠癌(8.6%,86/1003)、胃癌(6.6%,89/1358)、甲状腺癌(4.7%,67/1437)和肺癌(3.9%,35/887)。当纳入所有SPC部位时,结直肠癌和乳腺癌患者的SPC的SIRs>1.0(分别为1.21和1.66)。乳腺癌和甲状腺癌表现出较高的部位相关性(P<0.05),结直肠癌与胃癌有较高的部位相关性(P<0.05)。本研究分析了被诊断患有五种器官原发性癌的癌症患者中SPC的发病率和模式。该研究结果可能有助于对癌症患者进行有效的SPC随访和早期检测。